Although further studies are needed to determine whether anti-PIA/PNAG antibodies can protect against E. coli infections, these initial studies confirm the potential of PIA/PNAG as a protective vaccine for diverse and common pathogens such as E. coli, S. aureus, and coagulase-negative staphylococci. The gene discussed is RICTOR; the disease is escherichia coli infection.